Vielight Neuro RX Gamma device and irradiation configuration used in the randomized, double-blind, sham-controlled trial.
Once-daily oral ICP-332 results in large reduction in eczema scores and shows favorable safety in adults with moderate-to-severe atopic dermatitis.
In a study of more than 31,000 adults, an EHR-integrated patient-facing tool significantly improved identification of ...
Ribupatide (KAI-9531) aims to address critical need for greater weight loss, especially for people living with a BMI of 35 kg ...
New research shows yoga helps individuals in rehab for opioid addiction recover more quickly and with decreased cravings, ...
Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases ...
New research has found that the benefits of graded sensorimotor retraining are likely to be similar for all patients with ...
Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...
Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.
BIRMINGHAM, AL, UNITED STATES, January 8, 2026 / EINPresswire.com / — Rampart, a Birmingham, Alabama–based medical device ...